Mirei Kobayashi

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Real-world pharmacokinetics of venetoclax in patients with acute myeloid leukemia in Japan.

Real-world pharmacokinetics of venetoclax in patients with acute myeloid leukemia in Japan.

Journal: Blood neoplasia

Published: August 12, 2025

Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin's Lymphoma: A Single-Center Cohort Study.

Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin's Lymphoma: A Single-Center Cohort Study.

Journal: Viruses

Published: February 05, 2024

Brentuximab Vedotin, Doxorubicin, Vinblastine, Dacarbazine(A+AVD)Therapy for Classical Hodgkin Lymphoma- A Single-Institution Experience

Brentuximab Vedotin, Doxorubicin, Vinblastine, Dacarbazine(A+AVD)Therapy for Classical Hodgkin Lymphoma- A Single-Institution Experience

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: October 06, 2023

New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination.

New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination.

Journal: International journal of hematology

Published: March 24, 2023

Booster effect of a third mRNA-based COVID-19 vaccine dose in patients with myeloid malignancies.

Booster effect of a third mRNA-based COVID-19 vaccine dose in patients with myeloid malignancies.

Journal: Cancer medicine

Published: March 01, 2023

Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms.

Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms.

Journal: Annals of hematology

Published: January 04, 2023

Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma.

Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma.

Journal: Annals of hematology

Published: November 11, 2022

Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia.

Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia.

Journal: British journal of haematology

Published: August 26, 2022

A Rare Case of BCL2-Positive Multiple Myeloma Complicated with Follicular Lymphoma.

A Rare Case of BCL2-Positive Multiple Myeloma Complicated with Follicular Lymphoma.

Journal: Case reports in hematology

Published: June 07, 2022

Humoral response to mRNA-based COVID-19 vaccine in patients with de novo and pre-existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination.

Humoral response to mRNA-based COVID-19 vaccine in patients with de novo and pre-existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination.

Journal: British journal of haematology

Published: May 25, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026